The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 02, 2023
Filed:
Jun. 08, 2022
Applicant:
Xwpharma Ltd., Grand Cayman, KY;
Inventors:
Assignee:
XWPHARMA LTD., Grand Cayman, KY;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/095 (2006.01); A61K 31/428 (2006.01); A61P 25/16 (2006.01); A61P 25/22 (2006.01); A61P 25/28 (2006.01); C07D 293/12 (2006.01); A61P 23/00 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/41 (2006.01); C07D 277/82 (2006.01);
U.S. Cl.
CPC ...
C07D 293/12 (2013.01); A61K 9/0053 (2013.01); A61K 9/7023 (2013.01); A61K 31/095 (2013.01); A61K 31/41 (2013.01); A61K 31/428 (2013.01); A61P 23/00 (2018.01); A61P 25/16 (2018.01); A61P 25/22 (2018.01); A61P 25/28 (2018.01); C07D 277/82 (2013.01);
Abstract
The present invention relates compounds of Formula (A), as well as their preparation and uses, and further relates pharmaceutical compositions comprising these compounds and their uses as modulators of dysfunctional glutamate transmission. The present invention also relates to uses of the compounds or pharmaceutical compositions in treating or preventing certain neurological and psychiatric disorders and diseases as well as cancer in humans.